Transforming Growth Factor-Beta (TGFβ) Signaling Pathway in Cholangiocarcinoma
Cholangiocarcinoma is a deadly cancer worldwide, associated with a poor prognosis and limited therapeutic options. Although cholangiocarcinoma accounts for less than 15% of liver primary cancer, its silent nature restricts early diagnosis and prevents efficient treatment. Therefore, it is of clinica...
Main Authors: | Panagiotis Papoutsoglou, Corentin Louis, Cédric Coulouarn |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-08-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/8/9/960 |
Similar Items
-
Heteronemin Induces Anti-Proliferation in Cholangiocarcinoma Cells via Inhibiting TGF-β Pathway
by: Hung-Yun Lin, et al.
Published: (2018-12-01) -
TGF-β1 expression is associated with invasion and metastasis of intrahepatic cholangiocarcinoma
by: Yijie Chen, et al.
Published: (2015-01-01) -
Long noncoding RNA ROR promotes breast cancer by regulating the TGF-β pathway
by: LingLi Hou, et al.
Published: (2018-09-01) -
Computational Recognition and Clinical Verification of TGF-β-Derived miRNA Signature With Potential Implications in Prognosis and Immunotherapy of Intrahepatic Cholangiocarcinoma
by: Zaoqu Liu, et al.
Published: (2021-10-01) -
Modulation of the TGF-β signaling pathway by long noncoding RNA in hepatocellular carcinoma
by: Mengzhen Han, et al.
Published: (2020-12-01)